Marshall Wace’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$729K Sell
61,231
-52,619
-46% -$538K ﹤0.01% 2287
2025
Q4
$1.13M Buy
113,850
+57,153
+101% +$546K ﹤0.01% 1863
2025
Q3
$507K Buy
+56,697
New +$525K ﹤0.01% 2227
2025
Q2
Sell
-137,112
Closed -$1.49M 2651
2025
Q1
$1.49M Buy
+137,112
New +$1.38M ﹤0.01% 1604
2024
Q4
Sell
-12,400
Closed -$139K 2542
2024
Q3
$139K Buy
+12,400
New +$132K ﹤0.01% 2341
2023
Q4
Sell
-1,386,159
Closed -$12.6M 2130
2023
Q3
$12.6M Buy
1,386,159
+1,332,042
+2,461% +$16M 0.03% 569
2023
Q2
$659K Buy
+54,117
New +$603K ﹤0.01% 1886
2022
Q2
Sell
-201,007
Closed -$3.22M 3373
2022
Q1
$3.22M Sell
201,007
-469,818
-70% -$8.45M 0.01% 1734
2021
Q4
$16.4M Sell
670,825
-332,620
-33% -$7.81M 0.03% 576
2021
Q3
$23.4M Buy
+1,003,445
New +$24.3M 0.1% 227
2021
Q2
Sell
-7,789
Closed -$286K 2608
2021
Q1
$286K Sell
7,789
-681,407
-99% -$24.1M ﹤0.01% 2141
2020
Q4
$25.9M Buy
689,196
+675,438
+4,909% +$20.9M 0.14% 149
2020
Q3
$300K Buy
+13,758
New +$289K ﹤0.01% 1368
2019
Q4
Sell
-749,989
Closed -$7.65M 1656
2019
Q3
$7.65M Buy
749,989
+499,989
+200% +$5.1M 0.06% 370
2019
Q2
$2.53M Hold
250,000
0.02% 708
2019
Q1
$2.5M Hold
250,000
0.02% 672
2018
Q4
$250K Hold
250,000
﹤0.01% 1246
2018
Q3
$2.4M Buy
+250,000
New +$2.43M 0.02% 636

Other funds holding AHCO

Marshall Wace's AHCO Position: Q1 2026 in Review

Marshall Wace reduced its AdaptHealth (AHCO) stake by 46% in Q1 2026, selling an estimated $538K and leaving 61,231 shares worth $729K. The position accounts for ﹤0.01% of the portfolio, ranked #2287.

Marshall Wace first reported a position in AHCO in Q3 2018 and has held it in 18 quarters since. The position peaked at $25.9M in Q4 2020. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Marshall Wace held 61,231 shares of AdaptHealth worth $729K as of Q1 2026.
  • Marshall Wace sold 52,619 AdaptHealth shares in Q1 2026, an estimated $538K.
  • AdaptHealth made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2287 holding.
  • Marshall Wace first reported a position in AdaptHealth in Q3 2018 and has held it in 18 quarters since.
  • Marshall Wace's AdaptHealth position peaked at $25.9M in Q4 2020.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.